《肝纤维化中西医结合诊疗指南》(Guidelines for the treatment of Chinese and western medicine in liver fibrosis).doc

《肝纤维化中西医结合诊疗指南》(Guidelines for the treatment of Chinese and western medicine in liver fibrosis).doc

  1. 1、本文档共17页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
《肝纤维化中西医结合诊疗指南》(Guidelines for the treatment of Chinese and western medicine in liver fibrosis)

《肝纤维化中西医结合诊疗指南》(Guidelines for the treatment of Chinese and western medicine in liver fibrosis) Guideline for diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western Medicine Department of infectious diseases, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 2008-11-18 Hepatic fibrosis can be considered as a disease name (K74.001) in the international classification of diseases (ICD-10), but it is mainly a histopathological concept. Liver fibrosis refers to the liver tissue extracellular matrix (ECM) components hyperplasia and abnormal deposition of lead to the liver structure or (and) functional pathologic changes, the structure is shown as capillarization and hepatic lobule and portal fibrosis; function can be expressed in liver dysfunction and portal hypertension etc.. The mechanism of its formation is mainly due to hepatitis viruses, alcohol, drugs and poisons, schistosomiasis, metabolic and genetic, cholestasis and autoimmune liver disease and other chronic liver injury stimulation, the activation of hepatic stellate cells in hepatic sinusoid, collagen and other ECM components of the metabolic imbalance, generated more than ECM deposition and degradation, promote liver tissue structure reconstruction. Liver fibrosis is found in most chronic liver diseases with different etiology. Further development can lead to cirrhosis, which seriously affects the health and life of the patients. The prospective study showed that chronic hepatitis B cirrhosis estimated annual incidence rate was 2.1%; in a study of patients with HBeAg negative chronic hepatitis B is an average of 9 years (1 ~ 18.4 years) follow-up study showed that the incidence rate of progression to cirrhosis 23%[1-3]. Therefore, anti liver fibrosis is an important treatment for chronic liver disease. In the twentieth Century 60~80, the morphological characteristics of hepatic fibrosis and its important role in chronic liver disease were clearly

您可能关注的文档

文档评论(0)

f8r9t5c + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档